dalteparin and idrabiotaparinux

dalteparin has been researched along with idrabiotaparinux in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Eikelboom, JW; Weitz, JI1
Büller, HR; Gallus, AS; Pillion, G; Prins, MH; Raskob, GE1

Trials

1 trial(s) available for dalteparin and idrabiotaparinux

ArticleYear
Enoxaparin followed by once-weekly idrabiotaparinux versus enoxaparin plus warfarin for patients with acute symptomatic pulmonary embolism: a randomised, double-blind, double-dummy, non-inferiority trial.
    Lancet (London, England), 2012, Jan-14, Volume: 379, Issue:9811

    Topics: Acute Disease; Adolescent; Adult; Aged; Aged, 80 and over; Anticoagulants; Biotin; Double-Blind Method; Drug Therapy, Combination; Enoxaparin; Factor X; Female; Humans; Intention to Treat Analysis; Male; Middle Aged; Oligosaccharides; Pulmonary Embolism; Warfarin

2012

Other Studies

1 other study(ies) available for dalteparin and idrabiotaparinux

ArticleYear
Idrabiotaparinux treatment for venous thromboembolism.
    Lancet (London, England), 2012, Jan-14, Volume: 379, Issue:9811

    Topics: Anticoagulants; Biotin; Enoxaparin; Factor X; Female; Humans; Male; Oligosaccharides; Pulmonary Embolism; Warfarin

2012